Conference PaperPDF Available

Results and realistic implications of the 2004 AHS-Merial heartworm survey

Authors:
  • Boehringer Ingelheim, Duluth, GA
  • Animal Medical Center of NE Alabama

Abstract

In 2005, a heartworm survey was sent out to over 25,000 veterinary practices by the American Heartworm Society, in cooperation with Merial. Responses were received from more than 12,000 veterinary clinics, and based upon these responses, more than 250,000 dogs in the US tested positive for heartworms in 2004. These numbers were up slightly from 244,000 positive dogs noted in a similar survey, with a similar response rate, performed in 2001. Although response rate was high, the survey data accounts for less than one-half of the total veterinary clinics in the United States. The American Veterinary Medical Association (AVMA) reported that, of the 61.6 million dogs in the US, 51.5 million (83.6%) are seen by veterinarians at least once a year.1 Furthermore, according to polls by Gallup2 and B&R Tracking3, heartworm disease preventives are only dispensed to ~58% of dog-owning households, a 8% decline from the 66% dispensing rate reported in 1998. The information on non-reporting clinics in the 2004 survey, AVMA data on dogs never seen by veterinarians, and decreased preventive dispensing, would indicate that heartworm disease is likely a much more significant issue than the AHS/Merial heartworm survey numbers indicate. Both the 2001 and 2004 heartworm surveys were performed to increase awareness and provide a tool for client education. They were intended to illustrate the need for heartworm disease prevention for pet owners and veterinary staff. While useful as an education tool, these surveys underestimate the prevalence of canine heartworm disease. These survey results demonstrate a need for continued, consistent and aggressive heartworm education. Future practitioners and veterinary technicians, current practitioners, clinic staff, and pet owners, all need education and awareness to decrease the real number of heartworm positive dogs in the US.
American Association
of
Veterinary Parasitologist
51
sl
Annual Meeting
Sheraton Waikiki Hotel, Honolulu, HI
were assigned to one
of
two treatment groups. There were three experimental animals in each treatment
group and each orally received therapeutic doses
of
either FBZ (group A) or MO (group B) mixed with
their food. Within 6 days
of
treatment with FBZ, there was a 100% reduction in the number
of
T.
trichiura eggs shed per gram
of
feces from all three baboons in group
A.
Fecal egg counts remained
negative for
T.
trichiura from group A baboons 60 days post-treatment. Conversely, comparisons
of
the
number
of
T.
trichiura eggs shed per gram
of
feces pre- and post-treatment from group B baboons that
received MO showed that there was not a significant reduction. The number
of
T.
trichiura eggs per gram
of
feces increased by 134.1% post-treatment for one
of
the baboons in group B whereas reductions in egg
counts
of
only 4.6% and 29.0% were observed from the other two baboons that received MO. During the
same time period
of
pre- and post-treatments fecal eggs count for
T.
trichiura from baboons in groups A
and B, a control baboon that did not receive anthelmintic treatment had a reduction
of
24.8% in the
number
of
T.
trichiura eggs shed per gram
of
feces. The results
of
this study indicate that FBZ was
extremely effective for treating baboons infected with
T.
trichiura whereas treatment with MO had little
to no effect.
62
Current
status
of
canine
heartworm
disease in
Korea
and
its potential public health importance.
SUNGSHIK SHIN
1
*,
SHINYOUNG
KANG\
lUNGKEE KWON
2
.
ICOLLEGE OF VETERINARY
MEDICINE, CHONNAM NATIONAL UNIVERSITY, GW ANGlU, KOREA, AND 2COLLEGE
OF
VETERINARY MEDICINE, CHONBUK NATIONAL UNIVERSITY, KOREA.
Since canine dirofilariasis in South Korea was first reported in 1962, the causative parasite, Dirofilaria
immitis,
is
continuing to spread within the country. A survey
of
canine dirofilariasis in five areas
of
South
Korea in 1994, for instance, revealed that 28.3%
of
127
dogs were infected with
D.
immitis. In 2001,
however, the prevalence
of
heartworm infection among
165
dogs in three breeding farms in the vicinity
of
Seoul, Korea was 50.3%. Between 2004 and 2005, another survey
of
can! ine dirofilariasis in lindo Island
showed that 254
of365
dogs (69.6%) were infected with
D.
immitis. Moreover, a highly endemic area
of
canine dirofilariasis was yet located in Asan where 26
of
30 dogs (86.7%) were infected. Presence
of
D.
immitis was also documented in other animals such as cats, raccoon dogs, harbor seals, and jaguars in
Korea. An echocardiographic study compared with necropsy findings performed on
12
lindo dogs
naturally infected with heartworms indicated that the adult hemtworms were located mostly in the
terminal branches
of
the pulmonary arteries rather than in the heart when the host was alive, but the
worms appeared to move toward the right ventricle shortly after the
he!
art
of
the infected dogs stopped
beating. Clinical signs
of
canine dirofilariasis did not necessarily con-elate with the number
of
adult
worms. Several field trials have been performed in Korea using commercial prophylactic agents with
avermectin derivatives
as
the active ingredient which included ivelmectin, selamectin and moxidectin. A
considerable variation in the accuracy
of
9 commercially available diagnostic kits was noticed. As the
incidence
of
canine dirofilariasis appears to be increasing in Korea, this entity represents an impOltant
zoonosis and indicates a need for familiarity with the pathologic features
of
the lesions and the
morphologic characteristics
of
the worm.
63
Results
and
realistic implications
of
the
2004 AHS-Merial
heartworm
survey. lORGE
GUERRER0
1
*,
CT NELSON
2
,
DS
CARITHERS
3
.
I
DEPT
OF PATHOBIOLOGY, SCHOOL OF
VETERINARY MEDICINE, UNIVERSITY
OF
PENNSYLVANIA, PHILADELPHIA, PA,
2AMERICAN HEARTWORM SOCIETY (PRESIDENT), ANIMAL MEDICAL CENTER, ANNISTON,
AL AND
3
M
ERIAL LIMITED, DULUTH, GA.
62
American Association
of
Veterinary Parasitologist
51
st Annual Meeting
Sheraton Waikiki Hotel, Honolulu, HI
In 2005, a heartworm survey was sent out to over 25,000 veterinary practices by the American
Heartworm Society, in cooperation with Merial. Responses were received from more than 12,000
veterinary clinics, and based upon these responses, more than 250,000 dogs in the US tested positive for
heartworms in 2004. These numbers were up slightly from 244,000 positive dogs noted in a similar
survey, with a similar response rate, performed in 2001. Although response rate was high, the survey data
accounts for less than one-half
of
the total veterinary clinics in the United States. The American
Veterinary Medical Association (AVMA) reported that,
of
the 61.6 million dogs in the US, 51.5 million
(83.6%) are seen by veterinarians at least once a year.
1
Furthermore, according to polls by Gallup2 and
B&R
Tracking
3
,
heartworm disease preventives are only dispensed to
~58%
of
dog-owning households, a
8% decline from the 66% dispensing rate reported in 1998. The information on non-reporting clinics in
the 2004 survey, A VMA data on dogs never seen by veterinarians, and decreased preventive dispensing,
would indicate that heartworm disease is likely a much more significant issue than the AHS/Merial
heartworm survey numbers indicate. Both the
2001 and 2004 heartworm surveys were performed to
increase awareness and provide a tool for client education. They were intended to illustrate the need for
heartworm disease prevention for pet owners and veterinary staff. While useful as an education tool, these
surveys underestimate the prevalence
of
canine heartworm disease. These survey results demonstrate a
need for continued, consistent and aggressive heartworm education. Future practitioners and veterinary
technicians, current practitioners, clinic staff, and pet owners, all need education and awareness to
decrease the real number
of
heartworm positive dogs in the US.
64
Data
from
the
1992-2002
annual
heartworm
surveys
for
Ontario,
Canada
and
effectiveness
of
preventive
medication. OWEN SLOCOMBE*, DEPARTMENT OF PATHOBIOLOGY, ONTARIO
VETERINARY COLLEGE, UNIVERSITY OF GUELPH, GUELPH, ONTARIO,
CANADA.
In Canada, annual questionnaire surveys for Dirofilaria immitis in dogs were conducted since 1976. Data
from a small section
of
the 1992 - 2002 surveys is presented for the province
of
Ontario, the primary
focus
of
heartworm (HW) infection in Canada. During that period, cases reported for Canada and Ontario
ranged from 327 - 812 and 240 - 676 respectively. Other information presented here is only for Ontario
with ranges for the 1992 - 2002 period. The response rate to the questionnaires was 60 - 73%. Number
of
blood tests reported and prevalence estimated were 255,360 - 289,289 and 0.09% - 0.25% respectively.
Exceptionally few dogs (range 20 - 84) that had preventive medication tested
HW
positive. Most positive
dogs (range 233 - 612) never had medication.
HW
cases/20,000 tests for dogs that had medication ranged
from 1.9 - 7.4 and for dogs that did not from 95.7 - 203.0. From 1993 onwards, there was a gradual trend
upwards in numbers in all those parameters with a marked increase in 1996 - 1998, a marked decline in
2000 and subsequently a gradual decline to 2002. For about 53%
of
HW
dogs that had medication, the
owners admitted to missing medicating or improper dosage. For the other 47%, principal reasons were the
dogs the previous year and prior to medication were (1) diagnosed with
HW
and (a) not given an
adulticide, or (b) given an adulticide but with inadequate or no determination
of
its effectiveness, (2)
tested only for microfilariae and negative, but the next year tested for antigen and positive, (3) not tested
or tested negative (type
of
test unknown) and the next year tested at another clinic and positive. Owner
non-compliance with use
of
HW
preventive medication and product failure were minor issues during
1992-2002.
63
... The first survey conducted in 2002 requesting diagnostic data for 2001 had the participation of 15,366 clinics which reported diagnosing heartworm infections in 244,291 dogs. The second survey conducted in 2005 reviewing data for 2004 had the participation of 12,173 clinics (out of a total of 25,000), which reported 250,000 cases of canine heartworm infections diagnosed that year (Guerrero et al., 2006). Interestingly, 8,800 of the responders in the second 149 Epidemiology and prevention survey had also responded in the first survey. ...
... The first survey conducted in 2002 requesting diagnostic data for 2001 had the participation of 15,366 clinics which reported diagnosing heartworm infections in 244,291 dogs. The second survey conducted in 2005 reviewing data for 2004 had the participation of 12,173 clinics (out of a total of 25,000), which reported 250,000 cases of canine heartworm infections diagnosed that year (Guerrero et al., 2006). Interestingly, 8,800 of the responders in the second 149 Epidemiology and prevention survey had also responded in the first survey. ...
... The first survey conducted in 2002 requesting diagnostic data for 2001 had the participation of 15,366 clinics which reported diagnosing heartworm infections in 244,291 dogs. The second survey conducted in 2005 reviewing data for 2004 had the participation of 12,173 clinics (out of a total of 25,000), which reported 250,000 cases of canine heartworm infections diagnosed that year (Guerrero et al., 2006). Interestingly, 8,800 of the responders in the second 149 Epidemiology and prevention survey had also responded in the first survey. ...
... The first survey conducted in 2002 requesting diagnostic data for 2001 had the participation of 15,366 clinics which reported diagnosing heartworm infections in 244,291 dogs. The second survey conducted in 2005 reviewing data for 2004 had the participation of 12,173 clinics (out of a total of 25,000), which reported 250,000 cases of canine heartworm infections diagnosed that year (Guerrero et al., 2006). Interestingly, 8,800 of the responders in the second 149 Epidemiology and prevention survey had also responded in the first survey. ...
... For heartworm, it was not surprising that infection rates were highest overall in the southern states, as this area is well-known by veterinarians to be beset by clinical heartworm disease. Indeed, the map of percent positive tests for D. immitis generated from our data ( Fig. 1) corresponds well with the map of reported cases compiled by the American Heartworm Society (Guerrero et al., 2006), including having the highest prevalence of infections in the coastal states of the southeastern U.S. (SC 5.7%, GA 2.7%, AL 3.4%, MS 7.4%, LA 6.0%, and TX 5.5%) and a relatively low prevalence of infection in pet dogs in Florida (1.8%), where veterinarians and clients may be particularly conscientious about administering preventatives yearround. Also, as with the AHS map, there is a similar indication that the infection is more common along the Mississippi River (AR 6.8%, MO 2.0%, TN 3.6%). ...
Article
We evaluated a comprehensive national database that documents canine infection with, or exposure to, four vector-borne disease agents, Dirofilaria immitis, Borrelia burgdorferi, Ehrlichia canis, and Anaplasma phagocytophilum in order to assess geographic trends in rates of positive tests. While the percent positive test results varied by agent in different regions of the United States, with D. immitis antigen and antibodies to E. canis more commonly identified in dogs from the South (3.9% and 1.3%, respectively), and antibody to B. burgdorferi and A. phagocytophilum found more frequently in dogs from the upper Midwest and Northeast (4.0-6.7% and 5.5-11.6%, respectively), evidence of at least one agent was found in dogs from every state considered. Furthermore, each organism also appeared to occur in endemic foci within larger areas of relatively low prevalence. Relocation of infected or previously exposed dogs from endemic regions likely accounts for some of the unexpected geographic distribution seen, although local transmission in previously under-recognized areas of endemicity could also be occurring. Although data were only available from the 48 contiguous states (Alaska and Hawaii were not included), taken together, our results suggest that these disease agents may be present over a wider geographic area, and thus pose greater animal and public health risks, than is currently recognized. Dogs can serve as sentinels to identify the presence of vector-borne disease agents of both veterinary and public health significance.
Article
Full-text available
Canine Dirofilariasis is a vector-borne zoonotic parasitic disease primarily affecting dogs, cats, and wild carnivores. The disease is caused by the filarial nematodes of Dirofilaria repens and Dirofilaria immitis. In this paper, we review the epidemiology, diagnosis, treatment, and control of canine Dirofilariasis and its zoonotic importance. The intermediate hosts and vectors are different species of culicid mosquitoes of the genera Culex, Aedes, and Anopheles. The biting of infected mosquito vectors causes transmission to both animals and humans. The adult Dirofilaria immitis is found within the right ventricle, pulmonary artery, and posterior vena cava. Dirofilaria repens found in subcutaneous tissue whereas the microfilariae are found in the blood and lymph, and that way it results in the right ventricular hypertrophy with pulmonary arterial enlargement and increased bronchial opacification. The main clinical manifestations of Dirofilariasis infection include chronic congestive right-sided heart failure, pneumonitis, pulmonary hypertension, pulmonary thromboembolism, corpulmonale (Caval syndrome), subcutaneous nodules, multifocal nodular dermatitis, pruritus, and conjunctivitis. Canine Dirofilariasis is diagnosed through a microscopic examination of blood (Knott's test), a serological test, Molecular method, radiography, echocardiography, and electrocardiography. The appropriate therapeutic strategies include medical treatment, surgical treatment, and Wolbachia as a therapeutic target. The prevention of Dirofilaria infection is largely based on the regular use of ivermectin and milbemycin oxime.
Article
Background Canine heartworm (Dirofilaria immitis) was reported as endemic to South Australia over 25 years ago, but the current status of canine heartworm infection in South Australia is unknown. Methods We surveyed South Australian veterinary practices to collect evidence about canine heartworm cases, prevention, screening and treatment practices. Results In total, 141 veterinary practices operating in South Australia (92.3% response rate) completed a 12‐question telephone survey. Five confirmed cases of heartworm and one suspected false‐positive case were reported from separate practices over the 2016–17 financial year. All confirmed cases had recently relocated to South Australia from interstate. Incidence of canine heartworm was estimated at 0.00% (95% confidence interval (CI): 0.00–0.0006) and prevalence at 0.002% (95%CI: 0.00–0.004) using conservative estimates of the South Australian dog population. Attitudes and protocols regarding heartworm differed significantly between metropolitan and rural veterinary practices. All metropolitan practices recommend systematic medicated prevention against heartworm, while some rural practices (20.7%) recommend prevention only when travelling interstate (P < 0.001). Conclusion Although there is a minor source of heartworm from introduction of infected dogs into South Australia, there is no evidence that the infection is transmitted to other dogs within the state. Therefore, it is unlikely that heartworm is currently endemic to South Australia as reported in the past. This new evidence provides a strong case to refine current prevention practices to reflect the current negligible risk of heartworm infection within South Australia.
Article
Full-text available
An examination of the Companion Animal Parasite Council's (CAPC) canine heartworm data to clarify the spatial prevalence of heartworm in the United States. Factors thought to influence the spatial risk of disease, as identified in a recent CAPC workshop, are discussed.
Article
Full-text available
Dirofilariasis represents a zoonotic mosaic, which includes two main filarial species (Dirofilaria immitis and D. repens) that have adapted to canine, feline, and human hosts with distinct biological and clinical implications. At the same time, both D. immitis and D. repens are themselves hosts to symbiotic bacteria of the genus Wolbachia, the study of which has resulted in a profound shift in the understanding of filarial biology, the mechanisms of the pathologies that they produce in their hosts, and issues related to dirofilariasis treatment. Moreover, because dirofilariasis is a vector-borne transmitted disease, their distribution and infection rates have undergone significant modifications influenced by global climate change. Despite advances in our knowledge of D. immitis and D. repens and the pathologies that they inflict on different hosts, there are still many unknown aspects of dirofilariasis. This review is focused on human and animal dirofilariasis, including the basic morphology, biology, protein composition, and metabolism of Dirofilaria species; the climate and human behavioral factors that influence distribution dynamics; the disease pathology; the host-parasite relationship; the mechanisms involved in parasite survival; the immune response and pathogenesis; and the clinical management of human and animal infections.
Article
This article is a review of the systematics, taxonomy, biology, prevention, control, and treatment of the canine heartworm, Dirofilaria immitus. This filarioid parasite remains one of the most important and dangerous diseases of the dog throughout the United States. The geographic range of the parasite is expanding, and in many parts of the country it has emerged as a threat to canine welfare only in the last 50 or so years. The article also discusses the pathophysiological mechanisms behind the disease induced, the means for diagnosing the disease, and the means of assessing the success of therapy. The treatment of potential complications of heartworm infection, such as post-adulticide thromboembolism, eosinophilic granulomatous pneumonitis, and caval syndrome, is also discussed.
ResearchGate has not been able to resolve any references for this publication.